Option Care Health, Inc. (NASDAQ:OPCH) Receives $30.14 Average Price Target from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given an average rating of “Hold” by the seven analysts that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $30.14.

OPCH has been the topic of a number of research analyst reports. JMP Securities increased their price target on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. UBS Group started coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st.

Option Care Health Price Performance

Option Care Health stock opened at $22.85 on Tuesday. The stock’s 50 day moving average is $24.02 and its 200 day moving average is $28.02. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The firm has a market cap of $3.89 billion, a P/E ratio of 19.20, a P/E/G ratio of 2.43 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. UMB Bank n.a. lifted its stake in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares during the period. International Assets Investment Management LLC boosted its stake in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the period. Finally, Quarry LP grew its position in Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.